Pharmacy and Poisons Board Warns Against Poor Storage of Health Products

The Pharmacy and Poisons Board (PPB) has raised concerns over the improper storage and handling of Health Products and Technologies (HPTs), warning that such negligence is compromising patient safety.

The Board has received multiple market complaints linking product degradation to failures in maintaining recommended temperature and humidity conditions.

As the National Regulatory Authority responsible for overseeing the pharmacy profession and HPTs under the Pharmacy and Poisons Act (CAP 244), the Board has emphasized the need for strict adherence to Good Distribution Practices (GDP).

These guidelines ensure product integrity and efficacy across the supply chain, from manufacturers to healthcare facilities.

“Improper storage and handling of health products can lead to reduced efficacy, safety risks, and negative patient health outcomes,” the Board stated. “We are committed to enforcing compliance through inspections and regulatory actions, including product recalls and license suspensions where necessary.”

To mitigate these risks, the Board has directed all manufacturers, distributors, wholesalers, retailers, and healthcare facilities to adhere to the four guidelines including:

Conduct stability studies aligned with ICH Zone IVb climatic conditions to ensure HPTs withstand Kenya’s high temperatures and humidity.

Implement robust packaging to protect products from moisture, heat, and environmental stressors.

Clearly label storage conditions and special handling instructions on all product packaging.

Provide adequate training for supply chain stakeholders on best practices for handling temperature-sensitive products.

The Board has assured that it will intensify compliance audits to ensure adherence to these regulations.

Stakeholders found in violation may face enforcement actions, including penalties and recalls.

For further inquiries, stakeholders are encouraged to contact the Board at pms@ppb.go.ke.

By Sharon Atieno